Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

NCT01188798 ·Status: COMPLETED ·Phase: PHASE3

Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever

NCT04270786 ·Status: RECRUITING ·Phase: NA

A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

NCT00189748 ·Status: COMPLETED ·Phase: PHASE2

Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma

NCT07276737 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients

NCT06918834 ·Status: RECRUITING ·Phase: PHASE2

A Multicentre, Retrospective Study to Evaluate the Outcome of HSCT Mismatch Unrelated Donors

NCT04598789 ·Status: COMPLETED

Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies

NCT01751243 ·Status: WITHDRAWN ·Phase: PHASE1

Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD

NCT02848105 ·Status: UNKNOWN ·Phase: PHASE2

Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

NCT04965597 ·Status: COMPLETED ·Phase: PHASE2

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

NCT06517875 ·Status: RECRUITING ·Phase: PHASE2

A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies

NCT02623439 ·Status: TERMINATED ·Phase: PHASE2

Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

NCT00841724 ·Status: COMPLETED ·Phase: PHASE2

Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies

NCT00824135 ·Status: COMPLETED ·Phase: PHASE1

Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

NCT01428973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms

NCT05127174 ·Status: TERMINATED ·Phase: PHASE1

Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

NCT00454155 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT

NCT03733340 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis

NCT02593123 ·Status: COMPLETED ·Phase: PHASE2

Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia

NCT05975996 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH

NCT01212796 ·Status: UNKNOWN

Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies

NCT00566696 ·Status: COMPLETED ·Phase: PHASE2

Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

NCT06892223 ·Status: RECRUITING ·Phase: PHASE2

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT06859424 ·Status: RECRUITING ·Phase: PHASE2

Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies

NCT00202917 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen

NCT06362720 ·Status: NOT_YET_RECRUITING